Company intelligence / Profile preview

Center for Translational Research

Ownership: Private
Development stage: Other

Overview

The company provides comprehensive contract research and development services to the life science sector in Sweden and the Netherlands. It offers support across all phases of clinical trials as well as regulatory advice, DMPK/MIST and toxicology support, GLP-certified bioanalysis, quality assurance, project strategy planning, and manufacturing capabilities through its group companies.

Modalities: Small moleculeBiologicMedical device
Industry: Contract Research Organization

Partnerships

Collaborates with pharmaceutical developers needing CRO/CDMO/regulatory/bioanalytical services in Europe.Recent acquisition of Zelmic AB expands GMP-approved CRO/CDMO capabilities.

Beyond the preview

Go deeper on Center for Translational Research.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Center for Translational Research.

Explore the full profile